23 Pulmonary Embolism Clinical Trials in Nashville, TX (2026)

Q: Are there pulmonary embolism clinical trials in Nashville?

Yes, there are 23 pulmonary embolism clinical trials currently recruiting in Nashville, TX.

Q: How do I join a clinical trial in Nashville?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you.

Q: Are clinical trials in Nashville free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Pulmonary Embolism Studies in Nashville

NCT05734430Recruiting

Genetics of Appendix Cancer Study

The GAP Study is a prospective cohort study designed to comprehensively investigate genetic variations that may contribute to cancer development among individuals diagnosed with appendix/appendiceal c...

Nashville, TX700 participantsAndreana Holowatyj, PhD, MSCI

View Study Details

NCT03378557Recruiting

Periprosthetic Fracture Registry (PPFx)

This registry supports international data collection and research on PPFx treatments after hip and knee arthroplasty. A registry such as this ultimately aims to provide far-reaching benefits to socie...

Nashville, TX600 participantsAO Innovation Translation Center

View Study Details

NCT07146516Recruiting

Retinal Detachment Prevention (Laser Prophylaxis) in Stickler Syndrome (SS)

The goal of this clinical trial is to prospectively document to what extent the OSC/SS prophylactic laser retinopexy procedure works to prevent retinal detachment in SS in children and adults. Resear...

Nashville, TX500 participantsHelen Keller Eye Research Foundation

View Study Details

NCT05766670Recruiting

Intramedullary Calcium Sulfate Antibiotic Depot

The goal of this randomized clinical trial is to study the best treatment for open lower leg fractures to prevent infection. The main questions it aims to answer is if treating tibia fracture patients...

Nashville, TX497 participantsWake Forest University Health Sciences

View Study Details

NCT06293469Recruiting

Accelerated Flap Coverage in Severe Lower Extremity Trauma

The goal of this randomized controlled trial is to determine if accelerated flap coverage compared to standard flap coverage timing leads to improved infection-related complications in patients with o...

Nashville, TX356 participantsJohns Hopkins University

View Study Details

NCT07201948Recruiting

Team Lifestyle Immersion Hypertension Control Project

This project is focuses on reducing the risk and progression of hypertension among a population that records high incidence of hypertension and other chronic ailments such as heart disease, diabetes, ...

Nashville, TX220 participantsMeharry Medical College

View Study Details

NCT05584722Recruiting

Risk and Resilience in Pulmonary Arterial Hypertension and Genetically Susceptible Individuals

Pulmonary arterial hypertension (PAH) is a severe disease with a delayed diagnosis and markedly elevated mortality. High-risk populations, such as those with known genetic defects, provide a unique op...

Nashville, TX150 participantsVanderbilt University Medical Center

View Study Details

NCT07116434Recruiting

Discovery Diabetes

The goal of this clinical trial is to learn if the Discovery Program can help improve diabetes management in adolescents and young adults with type 1 diabetes (T1D). The main questions it aims to answ...

Nashville, TX150 participantsVanderbilt University Medical Center

View Study Details

NCT06055439Recruiting

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

The goal of this clinical trial is to evaluate CHM-2101, an autologous CDH17 CAR T-cell therapy for the treatment of advanced gastrointestinal (GI) cancers that are relapsed or refractory to at least ...

Nashville, TX135 participantsChimeric Therapeutics

View Study Details

NCT05334368Recruiting

Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial

This is a 52-week, randomized, placebo-controlled, double-blind, parallel group, multicenter study of depemokimab in adults with uncontrolled HES receiving standard of care (SoC) therapy. The study w...

Nashville, TX123 participantsGlaxoSmithKline

View Study Details

NCT06672510Recruiting

Safety and Effectiveness of the Akura Thrombectomy System for Use in the Removal of Emboli From the Pulmonary Arteries in Treating Acute Pulmonary Embolism (PE)

This study is a prospective, single-arm, interventional, multicenter study to evaluate the safety and effectiveness of percutaneous mechanical thrombectomy using the Akura Thrombectomy System in subje...

Nashville, TX118 participantsAkura Medical

View Study Details

NCT05641831Recruiting

Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study

This phase II trial tests how well canakinumab works to prevent progression to cancer in patients with clonal cytopenias of unknown significance (CCUS). CCUS is a blood condition defined by a decrease...

Nashville, TX110 participantsUma Borate

View Study Details

NCT05464095Recruiting

The MObile Health InterVEntion in Pulmonary Arterial Hypertension (MOVE PAH) Study

Patients with pulmonary arterial hypertension (PAH) have reduced health related quality of life (HRQOL) and impaired exercise capacity. Despite fourteen approved therapies, most patients die within te...

Nashville, TX100 participantsVanderbilt University Medical Center

View Study Details

NCT06057675Recruiting

Tranexamic Acid in Nasal Mohs Reconstruction

This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs reconstruction with local flaps at VUMC....

Nashville, TX100 participantsVanderbilt University Medical Center

View Study Details

NCT07062588Recruiting

Osteogenesis Imperfecta Trial of AGA2115 for ADUlts With COL1A1 and/or COL1A2 GeNetic Variations (IDUN)

This study will determine the effect of treatment of AGA2115 in adults with Type I, III, or IV osteogenesis imperfecta versus placebo....

Nashville, TX80 participantsAngitia Incorporated Limited

View Study Details

NCT04941599Recruiting

2-Hydroxybenzylamine (2-HOBA) to Reduce HDL Modification and Improve HDL Function in Familial Hypercholesterolemia (FH)

The Investigators will test the hypothesis that 2-HOBA will reduce modification of HDL and LDL and improve HDL function in humans with heterozygous FH. The Investigators plan to first study subjects w...

Nashville, TX72 participantsVanderbilt University Medical Center

View Study Details

NCT07142252Recruiting

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (...

Nashville, TX66 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT04502225Recruiting

Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure

Many persons with autonomic failure often have high blood pressure when lying down (supine hypertension). This study is exploring the impact of decreased venous return to the heart (achieved by raisin...

Nashville, TX44 participantsVanderbilt University Medical Center

View Study Details

NCT05587712Recruiting

Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)

The primary objectives of the study are to evaluate the safety and tolerability, and pharmacokinetics (PK) of sotatercept over 24 weeks of treatment in children ≥1 to \<18 years of age with PAH World ...

Nashville, TX42 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06609356Recruiting

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

This study aims to understand the heart and blood sugar health benefits of using an adjunctive therapy to lower high insulin levels in people with type 1 diabetes. The investigators will also look at ...

Nashville, TX27 participantsVanderbilt University Medical Center

View Study Details

NCT03042988Recruiting

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

Patients with autonomic failure are characterized by disabling orthostatic hypotension (low blood pressure on standing), and at least half of them also have high blood pressure while lying down (supin...

Nashville, TX20 participantsVanderbilt University Medical Center

View Study Details

NCT03312556Recruiting

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

Supine hypertension is a common problem that affects at least 50% of patients with primary autonomic failure. Supine hypertension can be severe and complicates the treatment of orthostatic hypotension...

Nashville, TX12 participantsVanderbilt University Medical Center

View Study Details

NCT07563322Recruiting

Mechanistic Study of Nicotinamide Riboside on NAD+ Biology in Individuals With Combined Pulmonary Hypertension

Pulmonary hypertension (PH) is a serious condition that puts strain on the heart and lungs and often leads to frequent hospital stays and shortened life expectancy. The most common cause is heart dise...

Nashville, TX10 participantsVanderbilt University Medical Center

View Study Details

About Pulmonary Embolism Clinical Trials in Nashville

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 23 pulmonary embolism clinical trials recruiting participants in Nashville, TX. These studies are seeking a combined 4,232 participants. Research is being sponsored by Andreana Holowatyj, PhD, MSCI, AO Innovation Translation Center, Helen Keller Eye Research Foundation and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Nashville — FAQ

Are there pulmonary embolism clinical trials in Nashville?

Yes, there are 23 pulmonary embolism clinical trials currently recruiting in Nashville, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Nashville?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Nashville research site will contact you about next steps.

Are clinical trials in Nashville free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Nashville studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 23 active trials in Nashville are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 13, 2026 from ClinicalTrials.gov